Lieven is a partner in McKinsey’s Geneva office. A doctor by training, he is a member of our Pharmaceuticals & Medical Products Practice and serves industry clients and public health bodies across Europe, North America, Asia, and Africa.
Lieven has extensive experience in commercial and medical functions, late development and lifecycle management, and BD. He has also been involved in a number of due diligence studies for clients undertaking mergers and acquisitions.
Among his recent projects, Lieven helped a US pharmaceutical company transform its operating model and organization design to address changing customer needs; supported a European public health body in preparing a program roll-out to more than a dozen countries; assisted a US generic drugs manufacturer in streamlining its supply-chain management; and advised an African government on its response plan for health emergencies.
Before joining McKinsey, Lieven qualified as a doctor at the Katholieke Universiteit Leuven and took an MSc and an MPhil in neuroscience at the University of Columbia. He also worked as a fellow with Columbia’s technology transfer office and as an intern with the Belgian Embassy in the Democratic Republic of Congo, analyzing healthcare systems in urban and rural areas.
Published work
“COVID-19 and cell and gene therapy: How to keep innovation on track,” McKinsey & Company, August 2020
“Not the last pandemic: Investing now to reimagine public-health systems,” McKinsey & Company, July 2020
“Public-private partnerships: An untapped strategic lever,” Unlocking Pharma Growth (PDF–2.91 MB), McKinsey & Company, 2012
“Optimizing clinical strategy to drive lifetime brand value” (PDF–87.5 KB), McKinsey & Company, August 2011
Education
University of Columbia
MPhil in neurobiology
University of Columbia
MA in neurobiology
Katholieke Universiteit Leuven
MD in medicine